Extend your brand profile by curating daily news.

FAQ: Trump's Support for Hemp THC Ban in Government Reopening Bill

By NewsRamp Editorial Team

TL;DR

Curaleaf Holdings Inc. may gain market advantage as the U.S. Senate spending bill prohibits hemp-derived THC products, potentially reducing competition from hemp-based alternatives.

The U.S. Senate approved a spending bill that includes a measure prohibiting hemp-derived THC products, marking a policy shift from the 2018 Farm Bill provisions.

This regulatory change aims to create clearer cannabis industry standards, potentially leading to safer consumer products and more responsible market development for future generations.

The spending bill ending the longest federal shutdown unexpectedly includes a major cannabis policy reversal, prohibiting hemp-derived THC products previously legal under the 2018 Farm Bill.

Found this article helpful?

Share it with your network and spread the knowledge!

FAQ: Trump's Support for Hemp THC Ban in Government Reopening Bill

The U.S. Senate approved a broad spending bill to end the longest federal government shutdown that includes a measure prohibiting hemp-derived THC products.

This represents a major shift in national cannabis policy since the passage of the 2018 Farm Bill, which had previously legalized hemp production.

The content indicates that President Trump supports the hemp THC ban included in the government reopening deal.

Marijuana industry players like Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF) are mentioned as watching how the marijuana industry will be affected.

CNW420 is a cannabis industry news service that releases an article each business day at 4:20 p.m. Eastern, providing concise, informative content about regulatory developments and their impact on financial markets.

Readers can receive SMS alerts by texting CANNABIS to 888-902-4192 (U.S. Mobile Phones Only).

Readers can visit https://www.CannabisNewsWire.com for more information and view full terms of use and disclaimers at https://www.CannabisNewsWire.com/Disclaimer.

CannabisNewsWire is based in Denver, CO, can be reached at 303.498.7722 Office, and contacted via email at Editor@CannabisNewsWire.com.

CannabisNewsWire is powered by IBN (Investor Brand Network).

blockchain registration record for this content
NewsRamp Editorial Team

NewsRamp Editorial Team

@newsramp

NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.